An Atlas of Organisation of Lipids in Extracellular Vesicles To Navigate Their Roles in Cancer Metastasis
This project aims to create an atlas of asymmetric lipid compositions in cancer-derived extracellular vesicles to understand their role in metastasis using advanced imaging techniques.
Projectdetails
Introduction
It is estimated that up to 90% of cancer deaths are caused not by the primary cancer but after it has metastasised, i.e. spread to other organs in the body. It is well known that the locations of metastasised tumours are specific to the location of the primary cancer.
Role of Extracellular Vesicles
Communication and transfer of material between cells is a fundamental process in cell biology, for which nature uses extracellular vesicles (EVs). These nanometre-sized vesicles are excreted by cells and contain signature combinations of:
- Membrane lipids
- Nucleic acids
- Proteins
- Surface markers
EVs excreted by cancer cells play an important role in communication between tumours and distant organs where metastases can take hold.
Overlooked Aspects of EV Research
While more is now understood about the role of EV nucleic acids, proteins, and surface markers in these processes, the role of EV lipid composition, and especially the role of asymmetric lipid distribution across the membrane, remains overlooked.
Research Objectives
I address this fundamental research question by developing an interdisciplinary approach for mapping the asymmetric lipid composition of EVs with varying pro-metastatic nature from a library of cancer cell lines.
- I will create an atlas of asymmetric lipid compositions of EVs excreted by cancer cell lines.
- This atlas will include quantitative data on the asymmetric lipid distribution between the inner and outer membrane leaflets (asymmetric lipid distribution).
Methodology
To study the role of EV lipid composition on selective uptake in cells from the original tumour and pre-metastatic environment, I will apply neutron scattering and super-resolution microscopy techniques.
Significance of the Research
Taken together, the atlas of cancer-derived EV asymmetric lipid compositions that I will develop represents a significant advance to the state of the art. It will be a ground-breaking combination of cell biology with engineering-based tools for chemical and biophysical in-depth characterisation of complex, asymmetric membranes.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.499.818 |
Totale projectbegroting | € 2.499.818 |
Tijdlijn
Startdatum | 1-3-2024 |
Einddatum | 28-2-2029 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- CHALMERS TEKNISKA HOGSKOLA ABpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Oncolipidomics: Why is lipidomic dysregulation pattern in blood similar for various cancers?The project aims to develop advanced lipidomic techniques to create a Cancer Lipidome Atlas, enhancing early cancer detection and treatment through comprehensive lipid profiling and data integration. | ERC Advanced... | € 3.499.413 | 2023 | Details |
Melanosomes as cancer immune modulators: a novel paradigm in melanoma immunityThis project aims to explore melanosomes' role in melanoma immunity to uncover new therapeutic strategies for treatment-resistant patients and enhance understanding of immune interactions. | ERC Advanced... | € 2.515.625 | 2024 | Details |
Regaining control of cancer at biological bordersBorderControl aims to identify molecular signals and mechanisms that enable cancer cells to breach physiological barriers, with the goal of uncovering novel biomarkers and therapeutic targets for metastasis. | ERC Advanced... | € 2.500.000 | 2024 | Details |
Decoding Extracellular Vesicle-mediated organ crosstalk in vivoThis project aims to investigate hepatic extracellular vesicle-mediated inter-organ communication in vivo using a transparent zebrafish model to enhance understanding of their role in health and disease. | ERC Starting... | € 1.500.000 | 2023 | Details |
Proteomic Analysis of Cell communication in TumorsThis project aims to analyze cancer proteome dynamics at single-cell resolution to understand tumor heterogeneity and improve personalized treatment for resistant metastatic cells. | ERC Consolid... | € 2.000.000 | 2022 | Details |
Oncolipidomics: Why is lipidomic dysregulation pattern in blood similar for various cancers?
The project aims to develop advanced lipidomic techniques to create a Cancer Lipidome Atlas, enhancing early cancer detection and treatment through comprehensive lipid profiling and data integration.
Melanosomes as cancer immune modulators: a novel paradigm in melanoma immunity
This project aims to explore melanosomes' role in melanoma immunity to uncover new therapeutic strategies for treatment-resistant patients and enhance understanding of immune interactions.
Regaining control of cancer at biological borders
BorderControl aims to identify molecular signals and mechanisms that enable cancer cells to breach physiological barriers, with the goal of uncovering novel biomarkers and therapeutic targets for metastasis.
Decoding Extracellular Vesicle-mediated organ crosstalk in vivo
This project aims to investigate hepatic extracellular vesicle-mediated inter-organ communication in vivo using a transparent zebrafish model to enhance understanding of their role in health and disease.
Proteomic Analysis of Cell communication in Tumors
This project aims to analyze cancer proteome dynamics at single-cell resolution to understand tumor heterogeneity and improve personalized treatment for resistant metastatic cells.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
3D spheroids derived from single cells for discovering stochastic patterns behind metastasis3DSecret aims to revolutionize cancer treatment by analyzing single circulating tumor cells using advanced technologies to uncover stochastic patterns driving metastasis and improve diagnosis and prognosis. | EIC Pathfinder | € 2.591.050 | 2023 | Details |
Geintegreerd systeem voor fractionering karakterisatie en kwantificatie van extracellulaire blaasjes en hun inhoudCelnext Biotechnologies onderzoekt de haalbaarheid van een geïntegreerd microfluidisch systeem met optische biosensoren voor gestandaardiseerde isolatie en analyse van extracellulaire blaasjes (EBs). | Mkb-innovati... | € 20.000 | 2021 | Details |
Novel peptide-based therapeutics for reprogramming the tumour stroma extracellular matrix using molecular modelling and computational engineeringThe project aims to develop TAX2, a novel peptide therapy targeting the tumor microenvironment to inhibit solid tumor progression and enhance immunotherapy efficacy, with a focus on ovarian cancer. | EIC Accelerator | € 2.434.790 | 2025 | Details |
automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationSThe NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring. | EIC Transition | € 2.497.750 | 2022 | Details |
A multiplexed biomimetic imaging platform for assessing single cell plasticity (Plastomics) and scoring of tumour malignancyThe PLAST_CELL project aims to develop a microfluidics-based imaging platform to quantify cancer cell plasticity, enhancing diagnosis and treatment of metastasis and therapy resistance. | EIC Pathfinder | € 2.982.792 | 2022 | Details |
3D spheroids derived from single cells for discovering stochastic patterns behind metastasis
3DSecret aims to revolutionize cancer treatment by analyzing single circulating tumor cells using advanced technologies to uncover stochastic patterns driving metastasis and improve diagnosis and prognosis.
Geintegreerd systeem voor fractionering karakterisatie en kwantificatie van extracellulaire blaasjes en hun inhoud
Celnext Biotechnologies onderzoekt de haalbaarheid van een geïntegreerd microfluidisch systeem met optische biosensoren voor gestandaardiseerde isolatie en analyse van extracellulaire blaasjes (EBs).
Novel peptide-based therapeutics for reprogramming the tumour stroma extracellular matrix using molecular modelling and computational engineering
The project aims to develop TAX2, a novel peptide therapy targeting the tumor microenvironment to inhibit solid tumor progression and enhance immunotherapy efficacy, with a focus on ovarian cancer.
automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationS
The NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring.
A multiplexed biomimetic imaging platform for assessing single cell plasticity (Plastomics) and scoring of tumour malignancy
The PLAST_CELL project aims to develop a microfluidics-based imaging platform to quantify cancer cell plasticity, enhancing diagnosis and treatment of metastasis and therapy resistance.